Trial to Evaluate the Efficacy of Supportive Therapy with Ginseng for Patients on Treatment with Regorafenib

What we are studying

The purpose of this study is to test whether ginseng can reduce the severity of the fatigue from the side effects of treatment.

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Ability to consent
  • Confirmed stage IV adenocarcinoma of the colon
  • Adequate bone marrow
  • Liver
  • And renal function

What is involved

  • Ginseng
  • Questionnaires
  • Blood draws


Parking compensation

Contact Information

Study Coordinator
Jennifer Thomas, RN
[email protected]

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.